![Carole Monterrat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Carole Monterrat
Eerdere bekende functies van Carole Monterrat
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sopartec SA
![]() Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Financieel Directeur/CFO | 01-03-2014 | 01-09-2018 |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Corporate Officer/Principal | 03-11-2009 | 01-03-2014 |
Opleiding van Carole Monterrat
Université de Bordeaux | Doctorate Degree |
Université Catholique de Louvain | Masters Business Admin |
Statistieken
Internationaal
België | 4 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Sopartec SA
![]() Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Finance |
- Beurs
- Insiders
- Carole Monterrat
- Ervaring